Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15718313 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient
Condition: Breast Cancer
Interventions: Drug: Adriamycin;   Drug: Docetaxel

Indicates status has not been verified in more than two years